Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Profil Institute, HighTide Biopharmaceutical partner to develop new therapies for diabetes and NAFLD/NASH Profil Institute for Clinical Research, a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, announced today a strategic master services agreement with Shenzhen HighTide Biopharmaceutical, a subsidiary of Shenzhen Hepalink Pharmaceutical.
Contract Research & Services > Contract Services > News
Almirall, Sun Pharma sign license deal to develop tildrakizumab for psoriasis in Europe Sun Pharma, Sun Pharmaceutical Industries and its subsidiaries or associate companies, and Almirall have signed a licensing agreement on the development and commercialization of tildrakizumab for psoriasis in Europe.
Contract Research & Services > Contract Services > News Kite Pharma announces exclusive license with NIH for anti-CD19 CAR product candidate Kite Pharma has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to a fully human anti-CD19 chimeric antigen receptor-based product candidate directed against B-cell malignancies.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Trek Therapeutics acquires two antiviral inhibitors from Vertex Pharmaceuticals
Trek Therapeutics has acquired the worldwide development and commercialization rights to treat infectious disease with lomibuvir (VX-222), a non-nucleoside inhibitor of the HCV NS5B polymerase and merimepodib (VX-497), an inhibitor of inosine monosphosphate dehydrogenase with broad-spectrum antiviral properties from Vertex Pharmaceuticals.
Contract Research & Services > Contract Services > News
Hybrigenics Services Introduces Hybribody
The new All-In-One service for the selection and validation of antibodies derived from a fully synthetic humanized VHH antibody library.
Contract Research & Services > Contract Services > Products
Hybrigenics Services - Protein Interactions Expert
Who else knows your protein better than you? Who else knows proteins interactions better than us?
Contract Research & Services > Contract Services > Suppliers
Chugai, Galderma sign license deal for nemolizumab
Chugai Pharmaceutical and Galderma Pharma have entered into a global license agreement for “nemolizumab” (CIM331) the anti-IL-31 receptor A humanized monoclonal antibody created by Chugai, which is currently under development for atopic dermatitis and pruritus in hemodialysis patients.
Contract Research & Services > Contract Services > News
Sapience Therapeutics signs license deal with Columbia University for novel cancer treatment
Sapience Therapeutics has entered into an exclusive license agreement with Columbia University to develop a first-in-class cancer treatment, which the Company refers to as ST-36.
Contract Research & Services > Contract Services > News
Stellar Biotechnologies, Neovacs establish new company in France
Stellar Biotechnologies and Neovacs announced the formation of Neostell, a simplified stock corporation headquartered in France, to carry out the business of the companies' joint venture, previously announced on May 11, 2016, to manufacture and sell conjugated therapeutic vaccines using Stellar's Keyhole Limpet Hemocyanin (KLH).
Contract Research & Services > Contract Services > News
GSK licenses intellectual property for respiratory disease target identified using Five Prime's platform
Five Prime Therapeutics announced that GSK exercised its option to take an exclusive license to the intellectual property related to a target under the respiratory diseases research collaboration between the companies, triggering a $1.5m license payment to Five Prime.
Contract Research & Services > Contract Services > News
RedHill Biopharma announces research collaboration with NIH for potential Ebola treatment
RedHill Biopharma signed a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease.
Contract Research & Services > Contract Services > News
Amgen, Daiichi Sankyo sign deal to commercialize biosimilars in Japan
Amgen and Daiichi Sankyo Company have signed an exclusive agreement to commercialize nine biosimilars in Japan.
Contract Research & Services > Contract Services > News
Aphios secures subcontract for nanoformulation of super hydrophobic anticancer drug
Aphios has been awarded a subcontract for the nanoformulation of a super hydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, MD.
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests